Literature DB >> 10947948

Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

C A Beeton1, E M Chance, L C Foukas, P R Shepherd.   

Abstract

Growth factors regulate a wide range of cellular processes via activation of the class-Ia phosphoinositide 3-kinases (PI 3-kinases). We directly compared kinetic properties of lipid- and protein-kinase activities of the widely expressed p110alpha and p110beta isoforms. The lipid-kinase activity did not display Michaelis-Menten kinetics but modelling the kinetic data demonstrated that p110alpha has a higher V(max) and a 25-fold higher K(m) for PtdIns than p110beta. A similar situation occurs with PtdIns(4,5)P(2), because at low concentration of PtdIns(4,5)P(2) p110beta is a better PtdIns(4,5)P(2) kinase than p110alpha, although this is reversed at high concentrations. These differences suggest different functional roles and we hypothesize that p110beta functions better in areas of membranes containing low levels of substrate whereas p110alpha would work best in areas of high substrate density such as membrane lipid rafts. We also compared protein-kinase activities. We found that p110beta phosphorylated p85 to a lower degree than did p110alpha. We used a novel peptide-based assay to compare the kinetics of the protein-kinase activities of p110alpha and p110beta. These studies revealed that, like the lipid-kinase activity, the protein-kinase activity of p110alpha has a higher K(m) (550 microM) than p110beta (K(m) 8 microgM). Similarly, the relative V(max) towards peptide substrate of p110alpha was three times higher than that of p110beta. This implies differences in the rates of regulatory autophosphorylation in vivo, which are likely to mean differential regulation of the lipid-kinase activities of p110alpha and p110beta in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947948      PMCID: PMC1221261     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.

Authors:  C A Beeton; P Das; M D Waterfield; P R Shepherd
Journal:  Mol Cell Biol Res Commun       Date:  1999-05

2.  Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.

Authors:  I D Hiles; M Otsu; S Volinia; M J Fry; I Gout; R Dhand; G Panayotou; F Ruiz-Larrea; A Thompson; N F Totty
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages.

Authors:  B Vanhaesebroeck; G E Jones; W E Allen; D Zicha; R Hooshmand-Rad; C Sawyer; C Wells; M D Waterfield; A J Ridley
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

4.  p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.

Authors:  T Asano; A Kanda; H Katagiri; M Nawano; T Ogihara; K Inukai; M Anai; Y Fukushima; Y Yazaki; M Kikuchi; R Hooshmand-Rad; C H Heldin; Y Oka; M Funaki
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

5.  A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity.

Authors:  C L Carpenter; K R Auger; B C Duckworth; W M Hou; B Schaffhausen; L C Cantley
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Purification and characterization of phosphoinositide 3-kinase from rat liver.

Authors:  C L Carpenter; B C Duckworth; K R Auger; B Cohen; B S Schaffhausen; L C Cantley
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

7.  p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring.

Authors:  M Funaki; H Katagiri; A Kanda; M Anai; M Nawano; T Ogihara; K Inukai; Y Fukushima; H Ono; Y Yazaki; M Kikuchi; Y Oka; T Asano
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

8.  Kinetic analysis of the coding properties of O6-methylguanine in DNA: the crucial role of the conformation of the phosphodiester bond.

Authors:  H B Tan; P F Swann; E M Chance
Journal:  Biochemistry       Date:  1994-05-03       Impact factor: 3.162

9.  Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85.

Authors:  P Hu; A Mondino; E Y Skolnik; J Schlessinger
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity.

Authors:  R Dhand; I Hiles; G Panayotou; S Roche; M J Fry; I Gout; N F Totty; O Truong; P Vicendo; K Yonezawa
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

View more
  27 in total

1.  Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo.

Authors:  Lazaros C Foukas; Caroline A Beeton; Jorgen Jensen; Wayne A Phillips; Peter R Shepherd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

3.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Role of phosphoinositide 3-OH kinase p110β in skeletal myogenesis.

Authors:  Ronald W Matheny; Melissa A Riddle-Kottke; Luis A Leandry; Christine M Lynch; Mary N Abdalla; Alyssa V Geddis; David R Piper; Jean J Zhao
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

5.  The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.

Authors:  Tamara Utermark; Trisha Rao; Hailing Cheng; Qi Wang; Sang Hyun Lee; Zhigang C Wang; J Dirk Iglehart; Thomas M Roberts; William J Muller; Jean J Zhao
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

Review 6.  The regulation of class IA PI 3-kinases by inter-subunit interactions.

Authors:  Jonathan M Backer
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting.

Authors:  Lauren M Thorpe; Haluk Yuzugullu; Jean J Zhao
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

8.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.

Authors:  Barbara Geering; Pedro R Cutillas; Gemma Nock; Severine I Gharbi; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

Review 9.  Targeting the phosphoinositide 3-kinase pathway in cancer.

Authors:  Pixu Liu; Hailing Cheng; Thomas M Roberts; Jean J Zhao
Journal:  Nat Rev Drug Discov       Date:  2009-08       Impact factor: 84.694

Review 10.  Should individual PI3 kinase isoforms be targeted in cancer?

Authors:  Shidong Jia; Thomas M Roberts; Jean J Zhao
Journal:  Curr Opin Cell Biol       Date:  2009-02-04       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.